Emla® cream has been widely used as a local anaesthetic for superficial procedures. Blanching and redness are commonly observed side-effects. We observed purpura in 5 patients after application of Emla®. Other authors have not reported this before. In 4 patients, purpura was observed after 30 min Emla® application before the treatment of mollusca contagiosa. In 1 patient, Emla® was used for 60 min before taking a lip biopsy. In these patients, patch tests were performed with the individual ingredients of Emla® cream, Emla® cream itself, placebo cream, and Tegaderm® plaster. All tests were negative at an early reading after 30 min as well as after 2 and 3 days. We concluded that the purpuric reaction was not of an allergic nature. Possibly, it was caused by a toxic effect on the capillary endothelium.

, , , , , ,
doi.org/10.1111/j.1600-0536.1997.tb00915.x, hdl.handle.net/1765/74024
Contact Dermatitis
Department of Dermatology

de Waard-van der Spek, F., & Oranje, A. (1997). Purpura caused by Emla® is of toxic origin. Contact Dermatitis, 36(1), 11–13. doi:10.1111/j.1600-0536.1997.tb00915.x